GlassScriptPhysician profile
Randolph B Shey
NPI 1417997636
$27,953.40
in general payments reported to CMS, 2019-2025
73 companies · $4,882 in 2025
The $4,882 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,043 · 2020: $1,389 · 2021: $4,114 · 2022: $4,732 · 2023: $4,931 · 2024: $4,861 · 2025: $4,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,204.60 |
| Education | $470.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,583.15 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $2,118.18 | 2019-2025 | Ingrezza, Ongentys |
| Abbvie INC. | $1,952.43 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Ucb, INC. | $1,724.36 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Biogen, INC. | $1,458.51 | 2019-2025 | Vumerity, Leqembi, Tysabri |
| Teva Pharmaceuticals USA, INC. | $1,417.12 | 2020-2025 | Austedo Xr, Austedo, Austedo Xr |
| Alexion Pharmaceuticals, INC. | $1,405.78 | 2019-2025 | Ultomiris, Soliris |
| Mdd US Operations, LLC | $1,254.62 | 2019-2025 | Gocovri, Gocovri |
| Pfizer INC. | $988.53 | 2021-2025 | |
| Emd Serono, INC. | $931.37 | 2019-2025 | Mavenclad, Mavenclad |
| Lilly USA, LLC | $874.75 | 2019-2025 | Emgality, Kisunla, Reyvow |
| Acadia Pharmaceuticals INC | $811.12 | 2019-2025 | Nuplazid |
| Amgen INC. | $794.38 | 2019-2025 | Uplizna |
| Csl Behring | $748.99 | 2019-2025 | Hizentra |
| Lundbeck LLC | $729.28 | 2021-2025 | Vyepti, Rexulti |
Show all 73 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randolph Shey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.